This research study is testing the combination of two drugs, sargramostim and pembrolizumab.
The study is designed to see if the combination of these study drugs would improve the
control of unresectable or metastatic melanoma cancer when compared to use of these drugs
alone.
The names of the study drugs involved in this study are:
- Pembrolizumab
- Sargramostim (GM-CSF)